Navigation Links
Professor Leroux From ETH Receives the Debiopharm Life Sciences Award 2010
Date:9/2/2010

rmaceutical Technology". Professor Leroux is an expert in galenic studies from the Swiss Federal Institute of Technology (ETH) in Zurich. He and his institute received CHF 100'000. Funded by Debiopharm, the ceremony took place at the EPFL (Ecole Polytechnique Federale de Lausanne) during the EPFL School of Life Sciences Symposium entitled "Engineering Life".

"We congratulate Professor Leroux for his outstanding research," said Rolland-Yves Mauvernay, President and founder of Debiopharm Group(TM). "A panel of experts from Debiopharm and the EPFL examined many high-level and promising applications from all over Europe; our decision to nominate Professor Leroux was unanimous. We were seduced by his innovative research, his general expertise and broad overall knowledge in drug delivery. The application file submitted by Professor Leroux was very comprehensive, with an impressive list of publications in high-impact factor pharmaceutical, materials and biomedical journals. He is a leading figure in an area that is likely to revolutionise medical therapeutics in the years to come."

The development of suitable drug formulations and delivery systems remains a major challenge in the full drug product development and industrialisation process. In his applied research, Professor Leroux is interested in the design of new carriers and materials for various pharmaceutical applications such as drug detoxification and the treatment of celiac disease (intolerance to gluten). Currently different approaches are being assessed as a supportive treatment of celiac disease. The polymeric binder technology which was developed in his laboratory will be further investigated. In parallel, he will examine another known strategy to study the stability of enzymes (exogenous propyl endopeptidases) in the gastro intestinal tract and try to improve it with various new polymers. He will also elaborate imaging tools to study in real time the enzymatic activity in vivo. Professor Leroux
'/>"/>

SOURCE The Debiopharm Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Professor-turned-producer learns the movie biz
2. UCF professor develops vaccine to protect against black plague bioterror attack
3. Stuart Parkin first distinguished professor at Eindhoven University of Technology
4. Yale professor T.P. Ma awarded the Connecticut Medal of Technology
5. UCF professor develops vaccine to protect against black plague bioterror attack
6. Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM)
7. Gift Aids Professor's Research into Vein Treatment
8. Thin films research lands engineering professor Air Force Young Investigator Award
9. Nyenrode Honorary Doctorate for Professor Michael E. Porter
10. Professor K. C. Nicolaou Speaks at WuXi AppTec
11. Professors Raphael Haftka and C. T. Sun to receive AIAA-ASC James H. Starnes, Jr. Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 2014 The science of light and ... with more than 200 primary students in a traveling ... University of Otago Physics Department and funded by an ... members of the university’s OSA/SPIE Student Chapter visited six ... giving children from small, rural schools hands-on lessons in ...
(Date:11/21/2014)... 20, 2014 The November 2014 issue ... an open access journal featuring the following articles:, ... to preserve photoresponsiveness in the retina , ... situ hybridization using chromogenic substrates in zebrafish , ... and protein electrophoresis , Nuclear LC3-positive puncta ...
(Date:11/21/2014)... , Nov. 20, 2014 Polaris Group ... dosed in its Phase 1 trial of ADI-PEG ... the treatment of malignant pleural mesothelioma (MPM) and ... conducting clinical trials on ADI-PEG 20, both as ... the treatment of several other indications, including breast ...
(Date:11/18/2014)... Sarasota, FL (PRWEB) November 17, 2014 ... novel point-of-care diagnostic tests – today announces its ... Control and Prevention’s (CDC) Get Smart About Antibiotics ... Antibiotics Week is a national campaign designed to ... local health departments, and non-profit and for-profit partners ...
Breaking Biology Technology:Optics and photonics outreach programs share science, spark fascination with light 2Optics and photonics outreach programs share science, spark fascination with light 3BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 2BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 3Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma 2RPS Again Partners with the CDC in Support of the 2014 Get Smart About Antibiotics Week 2RPS Again Partners with the CDC in Support of the 2014 Get Smart About Antibiotics Week 3
... CAMBRIDGE, England, June 25 ... service discovery services company at the,forefront of drug discovery ... Ahmedabad, India offering physio-chemical and CYP450 assays. , ... Biology Affiliate Partnership with,Hypoxium Ltd. UK. Hypoxium has specialist ...
... announced the winners of the NWO/Spinoza Prize for 2009. Two ... authors, Marten Scheffer and Albert van den Berg. The prize, ... Dutch award in science and is given for outstanding, pioneering ... EUR 1.5 million, but this year, each of the three ...
... June 24 KBI Biopharma, Inc. (KBI) announced today ... line generation with Crucell,s PER.C6(R) human cell line platform, ... on May 6, 2009. Under that agreement, KBI joins ... generation partner for licensees of the PER.C6(R) cell lines. ...
Cached Biology Technology:O2h and Hypoxium Announce an Agreement to Offer Hypoxium's Specialised In Vitro, Cell-Based Oncology Assays via O2h's Biology Affiliate Program 2KBI Biopharma Starts Cell Line Generation Process under Vendor Network Agreement for PER.C6(R) 2
(Date:11/4/2014)... Nov. 5, 2014 – University of Utah engineers developed ... help jet fuel produce electricity without needing to ignite ... to power portable electronics, off-grid power and sensors. , ... in the American Chemical Society journal ACS Catalysis ... a chemical reaction between a fuel and an oxygen-rich ...
(Date:11/4/2014)... 4, 2014   ...   Fuel3D , a developer of 3D ... round totaling $6.4 million (£4 million). This funding builds on ... this year and paves the way for the commercial launch ... The funding round was led by Chimera Partners and will ...
(Date:11/3/2014)... 3, 2014  NeuroSigma ® , Inc. (NeuroSigma), ... company focused on commercialization of its non-invasive ... treatment of neurological and neuropsychiatric disorders, announced today ... issued a Notice of Allowance for Mexican Patent ... by NeuroSigma and the Regents of the University ...
Breaking Biology News(10 mins):Jet-fueled electricity at room temperature 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3
... December 10, 2013, Shenzhen, China - Chinese researchers ... Medicine, BGI and other institutes identified the recurrent ... Yang 1) are related with insulinoma oncogenesis, implicating ... of functional pancreatic neuroendocrine tumors (PNETs). The latest ...
... has one of the fastest growing human populations in the ... density isn,t yet that high, the number of conflicts between ... on land areas grows. Angela Mwakatobe, who recently defended ... (NTNU) in Trondheim, has studied villages at various distances from ...
... a study led by McGill researcher Sarah Kimmins suggests that ... role in the health of their offspring. It also raises ... of food insecurity. The research focused on vitamin B9, ... green leafy vegetables, cereals, fruit and meats. It is well ...
Cached Biology News:Scientists identified T372R mutation as potential target for diagnosis and treatment of insulinoma 2Serengeti's animals under pressure 2Serengeti's animals under pressure 3You are what your father eats 2
Goat Anti-Horse IgG(T) Antibody, Unconjugated...
Identify and characterize Phosphoinositide (PI(3,4,5)P3) binding...
Mouse polyclonal antibody to MCFD2 - multiple coagulation factor deficiency 2...
Rabbit polyclonal to ErbB 2 (phospho Y1248) ( Abpromise for all tested applications). entrezGeneID: 2064 SwissProtID: P04626...
Biology Products: